117 related articles for article (PubMed ID: 25837433)
1. Chemoradiation therapy reduces aldehyde dehydrogenase 1 expression in cervical cancer but does not improve patient survival.
Lv Y; Yang L; Wang F
Med Oncol; 2015 May; 32(5):155. PubMed ID: 25837433
[TBL] [Abstract][Full Text] [Related]
2. A retrospective review of the prognostic value of ALDH-1, Bmi-1 and Nanog stem cell markers in esophageal squamous cell carcinoma.
Hwang CC; Nieh S; Lai CH; Tsai CS; Chang LC; Hua CC; Chi WY; Chien HP; Wang CW; Chan SC; Hsieh TY; Chen JR
PLoS One; 2014; 9(8):e105676. PubMed ID: 25148045
[TBL] [Abstract][Full Text] [Related]
3. Cancer stem-like cells of ovarian clear cell carcinoma are enriched in the ALDH-high population associated with an accelerated scavenging system in reactive oxygen species.
Mizuno T; Suzuki N; Makino H; Furui T; Morii E; Aoki H; Kunisada T; Yano M; Kuji S; Hirashima Y; Arakawa A; Nishio S; Ushijima K; Ito K; Itani Y; Morishige K
Gynecol Oncol; 2015 May; 137(2):299-305. PubMed ID: 25541259
[TBL] [Abstract][Full Text] [Related]
4. Aldehyde Dehydrogenase 1 Expression Predicts Chemoresistance and Poor Clinical Outcomes in Patients with Locally Advanced Cervical Cancer Treated with Neoadjuvant Chemotherapy Prior to Radical Hysterectomy.
Xie Q; Liang J; Rao Q; Xie X; Li R; Liu Y; Zhou H; Han J; Yao T; Lin Z
Ann Surg Oncol; 2016 Jan; 23(1):163-70. PubMed ID: 25916979
[TBL] [Abstract][Full Text] [Related]
5. Aldehyde dehydrogenase 1 (ALDH1) positivity correlates with poor prognosis in cervical cancer.
Yao T; Wu Z; Liu Y; Rao Q; Lin Z
J Int Med Res; 2014 Aug; 42(4):1038-42. PubMed ID: 24827824
[TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical analysis of cancer stem cell markers in invasive breast carcinoma and associated ductal carcinoma in situ: relationships with markers of tumor hypoxia and microvascularity.
Currie MJ; Beardsley BE; Harris GC; Gunningham SP; Dachs GU; Dijkstra B; Morrin HR; Wells JE; Robinson BA
Hum Pathol; 2013 Mar; 44(3):402-11. PubMed ID: 23036368
[TBL] [Abstract][Full Text] [Related]
7. The expression of ALDH1 in cervical carcinoma.
Yao T; Chen Q; Zhang B; Zhou H; Lin Z
Med Sci Monit; 2011 Aug; 17(8):HY21-26. PubMed ID: 21804471
[TBL] [Abstract][Full Text] [Related]
8. Putative stem cell markers in cervical squamous cell carcinoma are correlated with poor clinical outcome.
Hou T; Zhang W; Tong C; Kazobinka G; Huang X; Huang Y; Zhang Y
BMC Cancer; 2015 Oct; 15():785. PubMed ID: 26499463
[TBL] [Abstract][Full Text] [Related]
9. Stem cell markers aldehyde dehydrogenase type 1 and nestin expressions in renal cell cancer.
Ozbek E; Calik G; Otunctemur A; Aliskan T; Cakir S; Dursun M; Somay A
Arch Ital Urol Androl; 2012 Mar; 84(1):7-11. PubMed ID: 22649953
[TBL] [Abstract][Full Text] [Related]
10. Identification of brain tumour initiating cells using the stem cell marker aldehyde dehydrogenase.
Choi SA; Lee JY; Phi JH; Wang KC; Park CK; Park SH; Kim SK
Eur J Cancer; 2014 Jan; 50(1):137-49. PubMed ID: 24103144
[TBL] [Abstract][Full Text] [Related]
11. Cancer stem cell marker ALDH1 expression is associated with lymph node metastasis and poor survival in esophageal squamous cell carcinoma: a study from high incidence area of northern China.
Wang Y; Zhe H; Gao P; Zhang N; Li G; Qin J
Dis Esophagus; 2012 Aug; 25(6):560-5. PubMed ID: 22098156
[TBL] [Abstract][Full Text] [Related]
12. Pivotal role of CD38 biomarker in combination with CD24, EpCAM, and ALDH for identification of H460 derived lung cancer stem cells.
Karimi-Busheri F; Zadorozhny V; Li T; Lin H; Shawler DL; Fakhrai H
J Stem Cells; 2011; 6(1):9-20. PubMed ID: 22997842
[TBL] [Abstract][Full Text] [Related]
13. The prognostic role of the cancer stem cell marker aldehyde dehydrogenase 1 in head and neck squamous cell carcinomas: a meta-analysis.
Zhou C; Sun B
Oral Oncol; 2014 Dec; 50(12):1144-8. PubMed ID: 25264224
[TBL] [Abstract][Full Text] [Related]
14. ALDH1 & CD133 in invasive cervical carcinoma & their association with the outcome of chemoradiation therapy.
Javed S; Sood S; Rai B; Bhattacharyya S; Bagga R; Srinivasan R
Indian J Med Res; 2021 Aug; 154(2):367-374. PubMed ID: 35295009
[TBL] [Abstract][Full Text] [Related]
15. Clinical significance of Gremlin 1 in cervical cancer and its effects on cancer stem cell maintenance.
Sato M; Kawana K; Fujimoto A; Yoshida M; Nakamura H; Nishida H; Inoue T; Taguchi A; Takahashi J; Adachi K; Nagasaka K; Matsumoto Y; Wada-Hiraike O; Oda K; Osuga Y; Fujii T
Oncol Rep; 2016 Jan; 35(1):391-7. PubMed ID: 26530461
[TBL] [Abstract][Full Text] [Related]
16. Aldehyde dehydrogenase activity selects for the holoclone phenotype in prostate cancer cells.
Doherty RE; Haywood-Small SL; Sisley K; Cross NA
Biochem Biophys Res Commun; 2011 Nov; 414(4):801-7. PubMed ID: 22005464
[TBL] [Abstract][Full Text] [Related]
17. Aldehyde dehydrogenase-1 is a specific marker for stem cells in human lung adenocarcinoma.
Liang D; Shi Y
Med Oncol; 2012 Jun; 29(2):633-9. PubMed ID: 21484084
[TBL] [Abstract][Full Text] [Related]
18. Cancer Stem Cell Markers in Squamous Cell Carcinomas of the Salivary Glands.
Bertlich M; Kitz J; Kruizenga M; Spiegel JL; Canis M; Ihler F; Haubner F; Weiss BG; Jakob M
Oncology; 2021; 99(6):402-412. PubMed ID: 33756477
[TBL] [Abstract][Full Text] [Related]
19. Prognostic significance of tumor response as assessed by sequential 18F-fluorodeoxyglucose-positron emission tomography/computed tomography during concurrent chemoradiation therapy for cervical cancer.
Oh D; Lee JE; Huh SJ; Park W; Nam H; Choi JY; Kim BT
Int J Radiat Oncol Biol Phys; 2013 Nov; 87(3):549-54. PubMed ID: 24074928
[TBL] [Abstract][Full Text] [Related]
20. ALDH-1 expression levels predict response or resistance to preoperative chemoradiation in resectable esophageal cancer patients.
Ajani JA; Wang X; Song S; Suzuki A; Taketa T; Sudo K; Wadhwa R; Hofstetter WL; Komaki R; Maru DM; Lee JH; Bhutani MS; Weston B; Baladandayuthapani V; Yao Y; Honjo S; Scott AW; Skinner HD; Johnson RL; Berry D
Mol Oncol; 2014 Feb; 8(1):142-9. PubMed ID: 24210755
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]